Trademark Attorney / Law Firm
Philip Nash – Trademark Portfolio
Philip Nash specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 6 total filings concentrated in this category. The practice also covers Class 41 (Education & Entertainment) along with 4 other Nice Classification classes. Filing activity spans from 2013 to 2019. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Philip Nash's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademark applications has Philip Nash filed?
Philip Nash has filed 6 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does Philip Nash specialize in?
Philip Nash has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Philip Nash been filing trademarks?
Philip Nash's trademark filing history with the USPTO spans from 2013 to 2019, covering 6 years of trademark practice. During this period, Philip Nash has handled 6 trademark applications.
What is Philip Nash's trademark registration success rate?
Philip Nash has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.